Cargando…

Tumor Heterogeneity and Consequences for Bladder Cancer Treatment

SIMPLE SUMMARY: Bladder cancer is a heterogeneous disease that is composed of epithelia with varying transcriptional, mutational and lineage signatures. The epithelia of bladder tumors can also undergo pronounced changes in transcriptional and phenotypical qualities in response to progression, treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavallee, Etienne, Sfakianos, John P., Mulholland, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582570/ https://www.ncbi.nlm.nih.gov/pubmed/34771460 http://dx.doi.org/10.3390/cancers13215297

Ejemplares similares

Dealing with perioperative antiplatelet treatment for transurethral resection of the bladder: primum non nocere
por: Audenet, François, et al.
Publicado: (2018)

Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
por: Hass, Ralf, et al.
Publicado: (2020)

Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
por: Huang, Hai‐Ming, et al.
Publicado: (2020)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
por: Brouwer, Anja, et al.
Publicado: (2016)

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers
por: Sfakianos, John P., et al.
Publicado: (2020)

Breast tumor heterogeneity: causes and consequences
por: Polyak, K, et al.
Publicado: (2009)

Pursuing Quality in the Application of Bladder Cancer Quality of Life Research
por: Mohamed, N.E., et al.
Publicado: (2016)

Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression
por: Bordeleau, François, et al.
Publicado: (2023)

Contemporary outcomes of patients undergoing robotic-assisted radical cystectomy: A comparative analysis between intracorporeal ileal conduit and neobladder urinary diversions
por: Rich, Jordan M., et al.
Publicado: (2023)

Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells
por: Sprangers, Sara, et al.
Publicado: (2016)

Food insecurity and its consequences in indigenous children and youth in Canada
por: Banerji, Anna, et al.
Publicado: (2023)

Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
por: Sun, Xiao-xiao, et al.
Publicado: (2015)

Evidence of Atypical Recurrences After Robot-Assisted Radical Cystectomy: A Comprehensive Review of the Literature
por: Audenet, François, et al.
Publicado: (2017)

Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Reccia, Isabella, et al.
Publicado: (2023)

Optimal treatment and stochastic modeling of heterogeneous tumors
por: Badri, Hamidreza, et al.
Publicado: (2016)

Breast cancer intra-tumor heterogeneity
por: Martelotto, Luciano G, et al.
Publicado: (2014)

Tumor Endothelial Heterogeneity in Cancer Progression
por: Maishi, Nako, et al.
Publicado: (2019)

Functional and Oncological Outcomes of Female Pelvic Organ–preserving Robot-assisted Radical Cystectomy
por: Lavallée, Etienne, et al.
Publicado: (2021)

Psychosocial impact of penile carcinoma
por: Audenet, François, et al.
Publicado: (2017)

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
por: Wong, Jeffrey L., et al.
Publicado: (2023)

IL-15 synergizes with CD40 agonist antibodies to induce durable immunity against bladder cancer
por: Wong, Jeffrey L., et al.
Publicado: (2023)

Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer
por: Bryant, Geoffrey, et al.
Publicado: (2017)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States
por: Marqueen, Kathryn E, et al.
Publicado: (2019)

Vinflunine in the treatment of bladder cancer
por: Bachner, Mark, et al.
Publicado: (2008)

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer
por: Bidnur, S., et al.
Publicado: (2016)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans
por: van Rooijen, Dominique C, et al.
Publicado: (2010)

Intratumor Heterogeneity and Treatment Resistance of Solid Tumors with a Focus on Polyploid/Senescent Giant Cancer Cells (PGCCs)
por: Mirzayans, Razmik, et al.
Publicado: (2023)

Sprains : Their Consequences and Treatment
Publicado: (1888)

Sprains: Their Consequences and Treatment
Publicado: (1888)

Sprains, Their Consequences and Treatment
Publicado: (1894)

Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
por: Gao, Jian-Peng, et al.
Publicado: (2018)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?
por: Devi, Gayatri, et al.
Publicado: (2018)

Heterogeneity of Red Blood Cells: Causes and Consequences
por: Bogdanova, Anna, et al.
Publicado: (2020)

Highlight report: Functional consequences of urinary bladder cancer risk variants
por: Selinski, Silvia
Publicado: (2013)

Systematic review of population‐based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences
por: Caballero, José María, et al.
Publicado: (2022)

Heterogeneity of tumor cells in terms of cancer-initiating cells
por: Morii, Eiichi
Publicado: (2016)

Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
por: Albini, Adriana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p5c6efmftssfnhsrvi86srtt1a